Senti Biosciences (SNTI) Receivables - Net (2021 - 2025)
Senti Biosciences (SNTI) has 5 years of Receivables - Net data on record, last reported at $1.6 million in Q3 2025.
- For Q3 2025, Receivables - Net rose 77.78% year-over-year to $1.6 million; the TTM value through Sep 2025 reached $1.6 million, up 77.78%, while the annual FY2024 figure was $1.6 million, 1369.64% up from the prior year.
- Receivables - Net reached $1.6 million in Q3 2025 per SNTI's latest filing, down from $3.5 million in the prior quarter.
- Across five years, Receivables - Net topped out at $18.6 million in Q2 2024 and bottomed at $112000.0 in Q4 2023.
- Average Receivables - Net over 5 years is $3.4 million, with a median of $900000.0 recorded in 2024.
- Peak YoY movement for Receivables - Net: skyrocketed 3184.66% in 2024, then plummeted 88.23% in 2025.
- A 5-year view of Receivables - Net shows it stood at $483000.0 in 2021, then increased by 29.61% to $626000.0 in 2022, then plummeted by 82.11% to $112000.0 in 2023, then skyrocketed by 1369.64% to $1.6 million in 2024, then dropped by 2.79% to $1.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $1.6 million in Q3 2025, $3.5 million in Q2 2025, and $2.1 million in Q1 2025.